3 best performing ASX shares in the week of 4 April 2022

Marc Kennis Marc Kennis, April 11, 2022

Best performing ASX shares

The three best performing ASX shares in the week of 4 April 2022 were Legacy Iron Ore (ASX:LCY), up 60%, Hawsons Iron (ASX:HIO), up 46.4%, and Toro Energy (ASX:TOE), up 45%

 

GET A 30-DAY FREE TRIAL TO STOCKS DOWN UNDER

 
1. Legacy Iron Ore (ASX:LCY)

Industry: Resources

Legacy Iron Ore Limited (LCY) is a Western Australian-based company, focused on iron ore, base metals, tungsten and gold development and mineral discovery.

Market Cap: $205m

12 month high / low: $0.012 – $0.042

 

Legacy Iron Ore

 

 

2. Hawsons Iron (ASX:HIO)

Industry: Resources

Hawsons Iron Ltd (HIO, formerly Carpentaria Resources Ltd) is a mineral exploration company. HIO is currently focused on developing its flagship Hawsons Iron Project near Broken Hill, NSW into a premium producer of high-quality iron ore products for the global steel industry.

Market Cap: $293M

12 month high / low: $0.035 – $0.435

 

Hawson Iron

 

 

3. Toro Energy (ASX:TOE)

Industry: Energy

Toro Energy Limited (TOE) is an ASX listed uranium development and exploration company with projects in WA. Current focus of the company is on advancement and development of Wiluna Uranium Project and initiate exploration of Yandal gold project.

Market Cap: $113m

12 month high / low: $0.012 – $0.058

 

Toro Energy

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get the Latest Insider Trades on ASX!

Recent Posts

Electro Optic Systems (ASX:EOS) US$42m Slinger Order Lands as Defence Demand Heats Up

New Highs, New Contract, But Valuation Is Now the Debate Electro Optic Systems has pushed to new highs on the…

Sovereign Metals (ASX:SVM) Japan Wants Kasiya Rutile, 70,000 tpa Targeted

Kasiya gets a handshake from a Tier One Trading Partner Sovereign Metals surged 10% today after signing a memorandum of…

Immutep’s Phase 3 trial for Efti has gotten the chop and shares plunge >90%! What now for investors?

After nearly a week in suspense, Immutep (ASX:IMM) confirmed news about Efti that its investors did not want to hear,…